275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2022. Parexel International Corporation.
275 Grove St., Suite 101C, Newton, MA 02466
+1 617 454 9300
2520 Meridian Parkway, Research Triangle Park, Suite 200, Durham, NC 27713
+1 919 544 3170
© 2000-2022. Parexel International Corporation.
The first stages of a clinical trial can be tense. So, choosing a partner to share this critical phase of your drug’s journey is key. By working with us, you’ll gain a simplified and dedicated approach to initial stage testing.
Phase I is the first time a drug will be tested in people, and often involves a small group of volunteers with no underlying health conditions. Our team will administer testing in order to investigate dosage, side effects, and other safety measures to ensure your drug proceeds properly into the next phase. In this intial phase, we are trying to understand how the drug interacts with the body, if there are any side effects, and if the drug is safe to progress.
Our phase I clinical trails are delivered in our global network of early phase clinics located across three continents.
To further support your development, our Clinical Pharmacology, Modeling and Simulation solutions combine clinical pharmacology modeling and simulation with clinical PK/PD and pharmacometrics for a more strategic approach to clinical development.
But the most important thing we offer at this stage is an experienced team who recognize the time, technology and hope you’ve invested in your product so far, and are committed to taking it to the next phase.
Learn more about our first-in-man - or first-in-human (FiH) - and other Phase I safety studies.
Browse the Parexel Resource Center for our latest content on clinical trial supplies, logistics, innovation, drug safety, cell & gene therapy, and more!
The science of ethnobridging
View Now
Embarking on the Next Era of Precision Medicine
View Now
Precision Medicine Brochure
View Now
Industry Perspectives on Decentralized Clinical Trials
View Now
Innovating for the future of drug development
View Now
The Hidden Value of Early Patient Centricity: Practical Solutions for Early Phase Trials
View Now
Modifying Methods as seen in International Clinical Trials
View Now
Medical Writing Solutions
View Now
Decentralized Clinical Trials and Patient Needs
Watch Now
We are always available for a conversation.